BioSpace News Archive

Business

Anixa Biosciences Announces Partnership with ResearchDx for Launch of Cchek™ Prostate Cancer Confirmation Test

Anixa Biosciences, Inc., a biotechnology company focused on using the body’s immune system to fight cancer, announced that it has entered into a strategic alliance with ResearchDx to launch its Cchek™ Prostate Cancer Confirmation test as a Laboratory Developed Test.

February 25, 2019

·

4 min read

Policy

Exalenz Bioscience Receives Approval for Commercial Marketing in China for Its BreathID® Hp Lab System

Enhances company’s position to meet demand for H. pylori testing in China, a market with approximately 10 million breath tests annually

February 25, 2019

·

3 min read

Prometic secures additional USD $10 million (CAD $13.2 million) tranche from Structured Alpha LP, an affiliate of Thomvest Asset Management Inc., under its existing credit facilities

Prometic Life Sciences Inc. announced that it has secured an additional USD $10 million tranche from Structured Alpha LP, an affiliate of Thomvest Asset Management Inc., under the existing loan agreement originally entered into with SALP in November 2017.

February 25, 2019

·

4 min read

FDA

Bausch + Lomb Announces FDA Approval Of LOTEMAX® SM (loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery

LOTEMAX SM Is Formulated with SubMicron Technology for Efficient Penetration To Key Ocular Tissues1

February 25, 2019

·

9 min read

Deals

Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion

Danaher Corporation announced that it has entered into a definitive agreement with General Electric Company to acquire the Biopharma business of GE Life Sciences for a cash purchase price of approximately $21.4 billion.

February 25, 2019

·

7 min read

Job Trends

Marker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019

Marker Therapeutics, Inc. announced updated data from four clinical trials using the Company’s multi-antigen targeted T cell therapies.

February 25, 2019

·

7 min read

Business

Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine®

Titan Pharmaceuticals, Inc. announced the execution of a specialty pharmacy distribution and services agreement with AllianceRx Walgreens Prime that will expand patient access to treatment with Probuphine implant, Titan’s unique six-month maintenance treatment for opioid use disorder in eligible patients.

February 25, 2019

·

10 min read

Policy

Aurora Cannabis Receives Health Canada Licensing of Aurora Sky and MedReleaf Bradford

Sky and Bradford Facilities Combine for Over 128,000 kg per Year Production Capacity

February 25, 2019

·

5 min read

Policy

Aurinia Receives Notice of Allowance from the US Patent and Trademark Office for Claims Directed to Its Novel Voclosporin Dosing Protocol for Lupus Nephritis

Allowed claims cover an individualized flat-dosed pharmacodynamic treatment protocol utilized in the AURA-LV study and the ongoing AURORA study in lupus nephritis

February 25, 2019

·

8 min read

Drug Development

BRILINTA’s Phase III THEMIS Trial Met Primary Endpoint in Patients with Established Coronary Artery Disease and Type-2 Diabetes

BRILINTA reduced cardiovascular events in these patients with no prior heart attack or stroke

February 25, 2019

·

6 min read